Hamburg, Senior Panel Continue “Rethinking” FDA Organization
This article was originally published in The Tan Sheet
Commissioner Margaret Hamburg awaits recommendations from a panel of senior agency officials on how to ensure FDA’s centers support Office of Regulatory Affairs’ activities without duplication.
You may also be interested in...
FDA Commissioner Hamburg has appointed 10 officials to come up with a plan to realign the agency, with the goal of moving toward a “specialized program-based model.”
Commissioner Margaret Hamburg’s structural reorganization of FDA leaves the current leadership of the agency’s centers intact, but adds a new layer of management and accountability between the medical product center directors and the commissioner’s office.
John Taylor, counselor to FDA Commissioner Margaret Hamburg, will serve temporarily as second-in-command while Hamburg considers how to reorganize the agency's leadership following Principal Deputy Commissioner Josh Sharfstein's departure.